Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC has announced a significant change in its shareholder structure, with Calculus Capital Limited and Investec Wealth and Investment now collectively holding a reduced voting rights interest of 6.37%, down from the previous 7.96%. The notification, dated 21st August 2024, indicates that the threshold was crossed on 9th August 2024, affecting over 2.4 million voting rights.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
